×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MTLHY – mitsubishi ch grp u/adr (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MTLHY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/26
02:12 am
mtlhy
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items [Yahoo! Finance]
Low
Report
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items [Yahoo! Finance]
12/17
09:09 am
mtlhy
Mitsubishi Tanabe Pharma America Announces Research Collaboration Between Mitsubishi Tanabe Pharma Corporation and Dewpoint Therapeutics to Advance Small Molecule Condensate Modulator for ALS [Yahoo! Finance]
Low
Report
Mitsubishi Tanabe Pharma America Announces Research Collaboration Between Mitsubishi Tanabe Pharma Corporation and Dewpoint Therapeutics to Advance Small Molecule Condensate Modulator for ALS [Yahoo! Finance]
12/11
08:08 am
mtlhy
Classiq, Deloitte Tohmatsu, and Mitsubishi Chemical Compress Quantum Circuits by Up to 97% [Yahoo! Finance]
Low
Report
Classiq, Deloitte Tohmatsu, and Mitsubishi Chemical Compress Quantum Circuits by Up to 97% [Yahoo! Finance]
12/5
10:43 am
mtlhy
Government of Canada announces investment in Québec-based Aramis Biotechnologies [Globe and Mail, The (Toronto, Canada)]
Neutral
Report
Government of Canada announces investment in Québec-based Aramis Biotechnologies [Globe and Mail, The (Toronto, Canada)]
12/4
09:12 am
mtlhy
Mitsubishi Tanabe Pharma America to Present Data on Investigational ND0612 at the 2024 Annual Meeting of the Parkinson Study Group [Yahoo! Finance]
Low
Report
Mitsubishi Tanabe Pharma America to Present Data on Investigational ND0612 at the 2024 Annual Meeting of the Parkinson Study Group [Yahoo! Finance]
12/4
08:12 am
mtlhy
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation Enter Research Collaboration to Advance Small Molecule Condensate Modulator for ALS [Yahoo! Finance]
Low
Report
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation Enter Research Collaboration to Advance Small Molecule Condensate Modulator for ALS [Yahoo! Finance]
12/3
09:18 am
mtlhy
Mitsubishi Tanabe Pharma America to Present New ALS Research at MNDA's 35th International Symposium on ALS/MND [Yahoo! Finance]
Low
Report
Mitsubishi Tanabe Pharma America to Present New ALS Research at MNDA's 35th International Symposium on ALS/MND [Yahoo! Finance]
12/3
09:18 am
mtlhy
Martin Pharmaceuticals Secures Exclusive Rights From Mitsubishi Tanabe Pharma for Docarpamine to Treat Decompensated Chronic Liver Disease Including Ascites [Yahoo! Finance]
Low
Report
Martin Pharmaceuticals Secures Exclusive Rights From Mitsubishi Tanabe Pharma for Docarpamine to Treat Decompensated Chronic Liver Disease Including Ascites [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
4/7
MITSUBISHI CHEM/ADR (OTCMKTS: MTLHY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating.
-6.6%
5/17 MITSUBISHI CHEM/ADR (OTCMKTS: MTLHY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong sell" rating. -3.4%
4/30 Mitsubishi Chemical to Bolster Technology Platform Through Acquisition of American Organic and Inorganic Hybrid Chemicals Manufacturer Gelest from New Mountain Capital -2.5%
1/21 MITSUBISHI CHEM/ADR (OTCMKTS: MTLHY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -1.6%
5/17 MITSUBISHI CHEM/ADR (OTCMKTS: MTLHY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong sell" rating. -3.4%
4/30 Mitsubishi Chemical to Bolster Technology Platform Through Acquisition of American Organic and Inorganic Hybrid Chemicals Manufacturer Gelest from New Mountain Capital -2.5%
1/21 MITSUBISHI CHEM/ADR (OTCMKTS: MTLHY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: